Literature DB >> 20561143

Antiparasitic activity of the antimicrobial peptide HbbetaP-1, a member of the beta-haemoglobin peptide family.

A J Ullal1, E J Noga.   

Abstract

A family of antimicrobial peptides (AMPs) derived from the beta-subunit of haemoglobin was recently isolated from channel catfish, Ictalurus punctatus, infected with Ichthyophthirius multifiliis (ich), an important freshwater fish parasite that causes ichthyophthiriosis. We previously discovered that one of these AMPs, HbbetaP-1, had strong cidal activity against ich as well as another ectoparasite, Tetrahymena pyriformis. HbbetaP-1 toxicity was specific, primarily affecting the trophozoite (trophont) stage of ich. Here, we show that HbbetaP-1 acts more rapidly to kill smaller (presumably less mature) trophonts of ich, taking almost twice as long to kill larger trophonts (P < 0.0001). It acts more rapidly than an unrelated AMP, piscidin 1, which is haemolytic and also lethal to ich trophonts. HbbetaP-1 is potently and selectively lethal to the trophont stage of the dinoflagellate ectoparasite, Amyloodinium ocellatum, one of the most important pathogens of warmwater marine fish. HbbetaP-1 has no effect on the fish gill cell line feeder layer (G1B cells) used to propagate Amyloodinium, further suggesting a highly selective action. These findings suggest that HbbetaP-1 or related AMPs might function in protecting marine as well as freshwater fish and that HbbetaP-1 has highly selective activity against specific life stages of important fish ectoparasites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561143     DOI: 10.1111/j.1365-2761.2010.01172.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  7 in total

1.  Single Amino Acid Substitutions at Specific Positions of the Heptad Repeat Sequence of Piscidin-1 Yielded Novel Analogs That Show Low Cytotoxicity and In Vitro and In Vivo Antiendotoxin Activity.

Authors:  Amit Kumar; Amit Kumar Tripathi; Manoj Kathuria; Sonal Shree; Jitendra Kumar Tripathi; R K Purshottam; Ravishankar Ramachandran; Kalyan Mitra; Jimut Kanti Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

2.  Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells.

Authors:  Tinnakorn Theansungnoen; Surachai Maijaroen; Nisachon Jangpromma; Nualyai Yaraksa; Sakda Daduang; Theeranan Temsiripong; Jureerut Daduang; Sompong Klaynongsruang
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

3.  Impact of acute stress on antimicrobial polypeptides mRNA copy number in several tissues of marine sea bass (Dicentrarchus labrax).

Authors:  Genciana Terova; Anna G Cattaneo; Elena Preziosa; Giovanni Bernardini; Marco Saroglia
Journal:  BMC Immunol       Date:  2011-12-28       Impact factor: 3.615

4.  Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate.

Authors:  Sara Dabirian; Yasaman Taslimi; Farnaz Zahedifard; Elham Gholami; Fatemeh Doustdari; Mahdieh Motamedirad; Shohreh Khatami; Kayhan Azadmanesh; Susanne Nylen; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

Review 5.  Immunological properties of oxygen-transport proteins: hemoglobin, hemocyanin and hemerythrin.

Authors:  Christopher J Coates; Heinz Decker
Journal:  Cell Mol Life Sci       Date:  2016-08-12       Impact factor: 9.261

6.  Characterising the mechanisms underlying genetic resistance to amoebic gill disease in Atlantic salmon using RNA sequencing.

Authors:  Diego Robledo; Alastair Hamilton; Alejandro P Gutiérrez; James E Bron; Ross D Houston
Journal:  BMC Genomics       Date:  2020-03-30       Impact factor: 3.969

7.  High-Throughput Identification of Putative Antimicrobial Peptides from Multi-Omics Data of the Lined Seahorse (Hippocampus erectus).

Authors:  Xiyang Chen; Yunhai Yi; Xinxin You; Jie Liu; Qiong Shi
Journal:  Mar Drugs       Date:  2019-12-29       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.